| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |